RainBio, Inc.
RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases.
1
Funding Rounds
$500.0k
Money raised
Overview
RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma** Hi**** |
|
- | |
| Br*** Gi**** |
|
- |
Industries
RainBio, Inc. is active in the following industries: